Newsfeeds - Spark Newswire

2 minute read

Short Volatility Alert: Legend Biotech Corporation

Today, 6:37 AM

On Thursday, shares of Legend Biotech Corporation (NASDAQ: LEGN) experienced volatile short activity. After the activity, the stock price went up +6.97% to $51.10. The overall sentiment for LEGN has been Bullish.

LEGN

1 minute read

Legend Biotech Shares Move Higher After Bullish BMO Pitch

By Vandana Singh

Today, 6:37 AM

BMO Capital Markets initiated coverage on Legend Biotech Corporation (NASDAQ:LEGN) with a price target of $77, and an Outperform rating. The analyst…

JNJ

2 minute read

Uncategorized

Short Volatility Alert: Legend Biotech Corporation

By Christopher Sappo

Today, 6:37 AM

On Thursday, shares of Legend Biotech Corporation (NASDAQ: LEGN) experienced volatile short activity. After the activity, the stock price went down -1.38% to $42.96. The overall sentiment for LEGN has been Bullish.

LEGN

13 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For June 17, 2022

By Benzinga Insights

Today, 6:37 AM

Upgrades

ACHC

4 minute read

Events
News

Legend Biotech Announced Longer-Term Data from CARTITUDE Program Presented at ASCO Show Overall Response Rate Remains at 98% After More Than Two Years, With Median Progression-free and Overall Survival Not Yet Being Reached

By Charles Gross

Today, 6:37 AM

Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global biotechnology company developing, manufacturing and commercializing novel therapies to treat life-threatening diseases, presented today new and updated results from the CARTITUDE clinical development program studying ciltacabtagene autoleucel (cilta-cel) in t

LEGN

1 minute read

Legend Biotech Q1 EPS $(0.13) Up From $(0.30) YoY

By Benzinga Newsdesk

Today, 6:37 AM

Legend Biotech (NASDAQ:LEGN) reported quarterly losses of $(0.13) per share. This is a 56.67 percent increase over losses of $(0.30) per share from the same period last year.

LEGN

2 minute read

The Daily Biotech Pulse: Setback For NRx Pharma’s COVID Study, Fast Track Tag For Pfizer’s NASH Combo Therapy, Reata’s Ataxia Drug In FDA Review

By Vandana Singh

Today, 6:37 AM

Here's a roundup of top developments in the biotech space over the last 24 hours:

GOVX

1 minute read

Legend Biotech Reports Achievement Of $50M Milestone Under Its Collab Deal With J&J’s Janssen Biotech

By Benzinga Newsdesk

Today, 6:37 AM

LEGN

1 minute read

EMA’s CHMP Clears Janssen, Legend’s Multiple Myeloma CAR-T Therapy

By Vandana Singh

Today, 6:37 AM

The European Medicines Agency's CHMP

JNJ

1 minute read

Legend Biotech Q4 EPS $(0.30) Down From $(0.22) YoY, Sales $39.00M Down From $40.78M YoY

By Benzinga Newsdesk

Today, 6:37 AM

Legend Biotech (NASDAQ:LEGN) reported quarterly losses of $(0.30) per share. This is a 36.36 percent decrease over losses of $(0.22) per share from the same period last year. The company reported $39.00 million in sales

LEGN